Literature DB >> 15927896

Assessing the utility of a community pharmacy refill record as a measure of adherence and viral load response in patients infected with human immunodeficiency virus.

John F Inciardi1, Andrew L Leeds.   

Abstract

STUDY
OBJECTIVE: To assess the utility of a community pharmacy refill record as a measure of adherence to antiretroviral agents and as a predictor of viral load response.
DESIGN: Retrospective review of laboratory and community pharmacy records.
SETTING: University-based human immunodeficiency virus (HIV) clinic and local community pharmacy. PATIENTS: Ninety-four patients with HIV or the acquired immunodeficiency syndrome (AIDS) who visited both settings and had retrievable pharmacy and laboratory records.
MEASUREMENTS AND MAIN RESULTS: Community pharmacy records were compiled and screened for antiretroviral agent refill histories. The continuous, multiple-interval measure of medication gaps (CMG), a measure of drug nonadherence, was calculated for each antiretroviral agent. Viral load information was retrieved from the clinic records of patients who had a community pharmacy refill record documenting the previous 2 years. As refill nonadherence increased, viral load response increased, following an approximately sigmoid relationship. When the CMG score was less than 0.10, the viral load response did not change appreciably. The steepest rise in viral load response occurred with a CMG score ranging from 0.10-0.19. For values of 0.20 or greater, the viral load response was less sensitive to adherence performance. The probability (i.e., sensitivity) of having at least a 10% nonadherence record given a viral load greater than 1000 copies/ml was 80%.
CONCLUSION: The community pharmacy refill record is a convenient, accessible, and useful tool for assessing adherence and predicting viral load outcomes in patients with HIV and AIDS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15927896     DOI: 10.1592/phco.2005.25.6.790

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  7 in total

Review 1.  Practical and conceptual challenges in measuring antiretroviral adherence.

Authors:  Karina M Berg; Julia H Arnsten
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-01       Impact factor: 3.731

2.  Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring.

Authors:  James H McMahon; Michael R Jordan; Karen Kelley; Silvia Bertagnolio; Steven Y Hong; Christine A Wanke; Sharon R Lewin; Julian H Elliott
Journal:  Clin Infect Dis       Date:  2011-01-18       Impact factor: 9.079

3.  Utilizing Pharmacy Records to Assess Antibiotic Prescribing Patterns on the Incidence of Community-Acquired Methicillin-Resistant Staphylococcus aureus Infections in Children.

Authors:  Peter N Johnson; Robert P Rapp; Christopher T Nelson; J S Butler; Sue Overman; Robert J Kuhn
Journal:  J Pediatr Pharmacol Ther       Date:  2007-04

4.  Improved antiretroviral refill adherence in HIV-focused community pharmacies.

Authors:  Jennifer M Cocohoba; Patricia Murphy; Glen Pietrandoni; B Joseph Guglielmo
Journal:  J Am Pharm Assoc (2003)       Date:  2012 Sep-Oct

5.  Predictors of refill non-adherence in patients with heart failure.

Authors:  Johnson George; Stephen J Shalansky
Journal:  Br J Clin Pharmacol       Date:  2006-10-31       Impact factor: 4.335

6.  Potential for simplification of HIV treatment with boosted protease inhibitor monotherapy.

Authors:  Elena Reina; Ramón San Miguel; Natalia Larrea; Patricia Garcia; Victor Napal
Journal:  Int J Clin Pharm       Date:  2012-09-25

7.  Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patients.

Authors:  David Chromy; Philipp Schwabl; Theresa Bucsics; Bernhard Scheiner; Robert Strassl; Florian Mayer; Maximilian C Aichelburg; Katharina Grabmeier-Pfistershammer; Michael Trauner; Markus Peck-Radosavljevic; Thomas Reiberger; Mattias Mandorfer
Journal:  Wien Klin Wochenschr       Date:  2017-07-25       Impact factor: 1.704

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.